A Study of Zovaglutide in Subjects With Overweight or Obesity (HORIZON-1)

NCT07230119 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

744

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight , Obesity

Interventions

DRUG: Zovaglutide dose 1
DRUG: Zovaglutide dose 2
DRUG: Placebo

Sponsor

Beijing QL Biopharmaceutical Co.,Ltd